Stockscreener 앱 받기
2.19
4.37%
-0.10
시간 외 거래:
2.19
Telomir Pharmaceuticals Inc 주식(TELO)의 최신 뉴스
What analysts say about Telomir Pharmaceuticals Inc. stockFree Smart Trading Workshop - PrintWeekIndia
Telomir Pharmaceuticals Reports Telomir-1's Unique Profile Restores Mitochondrial Health While Improving Oxidative Stress Without Promoting Cell Proliferation in Diseased Human Cell Lines Highlighting Potential Relevance to Neurodegenerative Pathway - Lansing State Journal
What drives Telomir Pharmaceuticals Inc. stock priceUnstoppable profit momentum - PrintWeekIndia
When is the best time to buy Telomir Pharmaceuticals Inc. stockSuperior risk-adjusted returns - jammulinksnews.com
Telomir Pharmaceuticals stock surges on promising Progeria treatment results - Investing.com
Telomir Pharmaceuticals announces new preclinical data on Telomir-1 - TipRanks
Telomir-1 shows promise in restoring mitochondrial function By Investing.com - Investing.com South Africa
Telomir-1 shows promise in restoring mitochondrial function - Investing.com Australia
Revolutionary Mitochondrial Drug Could Transform Treatment of Alzheimer's, Parkinson's, and ALS - Stock Titan
Telomir Pharmaceuticals Inc. Stock Analysis and ForecastExceptional trading results - Autocar Professional
Telomir Pharmaceuticals Inc (NASDAQ: TELO) Stock Sentiment: What’s Wall Street Saying? - Stocksregister
Telomir Pharmaceuticals Inc (TELO) Stock: A Year of Stock Market Dynamics - investchronicle.com
Is Telomir Pharmaceuticals Inc. a good long term investmentExceptional trading results - jammulinksnews.com
What makes Telomir Pharmaceuticals Inc. stock price move sharplyGrowth Stock Monitor - Newser
Pre-market Movers: PMN, GCTK, TELO, SRPT... - RTTNews
Why Is Telomir Pharmaceuticals Stock (TELO) Up 150% Today? - MSN
Healthcare Stocks Move in Pre-Market Session: Telomir Pharmaceuticals, Mesoblast, and More - AInvest
Telomir Demonstrates Telomir-1 Reverses Epigenetic Gene Silencing of STAT1, Restoring Tumor Suppressor in Human Prostate Cancer Cells, Outperforming Chemotherapy and Rapamycin - Lohud
Telomir Pharmaceuticals Stock Price, Quotes and Forecasts - Benzinga
Telomir skyrockets on preclinical data backing epigenetic potential of lead asset - FirstWord Pharma
Dow Falls Over 200 Points; 3M Earnings Top Views - Benzinga
Telomir Pharma Skyrockets Nearly 139% After-Hours As Cancer Drug Shows Breakthrough Results, Beats Chemo In Human Cell Tests - NewsBreak: Local News & Alerts
Telomir Pharmaceuticals Skyrockets 150% on Breakthrough Preclinical Cancer Results - MSN
Telomir Pharmaceuticals shares surge 85.54% intraday after positive preclinical data for Telomir-1 in prostate cancer treatment. - AInvest
Telomir Pharmaceuticals: A Disruptive Force in Prostate Cancer Therapy with Epigenetic Innovation - AInvest
Telomir Pharmaceuticals stock soars after promising cancer treatment data - Investing.com
Telomir Pharma Jumps In After-Hours Trading After Drug Reverses Damage In Progeria Cells; Retail Eyes Bigger Gains - Stocktwits
0.97%
0.22%
자본화:
|
볼륨(24시간):